Cannabis Science Inc (OTCMKTS:CBIS) Set For the Grand Launch Of Its Two Pre ICO Pharmacies In High Traffic Areas

Cannabis Science Inc (OTCMKTS:CBIS) reported that the firm is preparing for the grand launch of its preliminary two Pre ICO Pharmacies in California. As per the update, these pharmacies will be run through the application of a Pharmacy Automation and Inventory Tracking Mechanism.

The buzz

Raymond C. Dabney, the CEO and Co-founder of Cannabis Science, expressed that the company’s Pharmacies are in major, high traffic places on Pico Boulevard in Los Angeles as well as on Ventura Boulevard located in the San Fernando Valley. The firm has also been given with a prospect to buy a potentially 60,000 square feet building in Los Angeles.

This is where the firm can establish its initial Cannabis Science Medical Center, counting full laboratory facilities, doctor and nurse clinics and patient intake. They will look at the prospective use of the firm’s US Federal Government Cage Code Clearance to offer Federal Government in the U.S. with permitted Emergency Medical Services.

The CEO of Cannabis Science expressed that it is possible they will include their sister firm, Crown Baus Capital Corp (OTCMKTS:CBCA) in this deal. Additional area will be leased to physician groups as well as other medical cannabinoid linked well-being providers and health services.

Dabney expressed that he is particularly thrilled about the planned Cannabis Science Medical Center, which was always one of their main objectives. This center will serve as a hub for their activities. Physicians can then consult directly with patients and the firm can coordinate and expand its international reach and research and development on cannabinoid-based medications linked to development initiatives via the CBIS Global Research Consortium.

Cannabis Science pharmacies are intended to be advanced facilities and they will be remarkable. They will showcase the entire product line, and additional offerings from select vendors that fulfill the high standards that they have established for their CBIS-branded products.

By Emily Gibson

Emily is a graduate from Chicago with a B.A. in Business and Economics. Emily specializes in the biotech and health care sector, but also has a penchant for medical marijuana stocks, mining, retail, and automotive stocks, as well as personal finance and macroeconomic topics of interest.

Leave a Reply

Your email address will not be published. Required fields are marked *

Cannabis Science Inc. (OTCMKTS:CBIS) To Enhance Information Sharing On All Company Initiatives And Interaction With The Public Through Cannabis Science Inc (OTCMKTS:CBIS) Is Ready To Proceed To The Next Level Cannabis Science Inc (OTCMKTS:CBIS) Ventures Into Multi-Billion USD Beverage Market Cannabis Science Inc (OTCMKTS:CBIS) Buys Second PRE ICO Dispensary Cannabis Science Inc (OTCMKTS:CBIS) Finalizes Deal Of its First PRE ICO Dispensary

Pin It on Pinterest